Mark Hennon
Papers
1
Total Citations
52
H-Index
1
About
Dr. Mark Hennon is a thoracic surgeon and researcher whose work centers on optimizing surgical outcomes for lung cancer patients, with a particular focus on the interplay between operative technique and oncologic efficacy. His most cited study, "The association of nodal upstaging with surgical approach and its impact on long-term survival after resection of non-small-cell lung cancer" (2019, 52 citations), is a landmark investigation into how surgical approach—whether open thoracotomy, video-assisted thoracic surgery (VATS), or robot-assisted thoracic surgery (RATS)—affects the accuracy of lymph node staging. By leveraging the National Cancer Database, Hennon demonstrated that nodal upstaging, a critical prognostic indicator, varies significantly by technique and directly correlates with long-term survival. This work has profound implications for clinical decision-making, challenging surgeons to prioritize thorough nodal dissection regardless of approach. Beyond this study, Hennon’s broader contributions to thoracic oncology have shaped best practices in minimally invasive surgery and cancer staging, earning him recognition as a leading voice in the field. His research continues to guide surgeons toward more precise, evidence-based care for non-small-cell lung cancer patients.
Research Focus
Key Achievements
Top Papers
- 1